Karen Smith
2016
In 2016, Karen Smith earned a total compensation of $2.1M as Executive Vice President, Research & Development and CMO at Jazz Pharmaceuticals, a 33% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $245,000 |
|---|---|
| Option Awards | $601,797 |
| Salary | $496,154 |
| Stock Awards | $740,159 |
| Other | $4,695 |
| Total | $2,087,805 |
Smith received $740.2K in stock awards, accounting for 35% of the total pay in 2016.
Smith also received $245K in non-equity incentive plan, $601.8K in option awards, $496.2K in salary and $4.7K in other compensation.
Rankings
In 2016, Karen Smith's compensation ranked 4,696th out of 14,075 executives tracked by ExecPay. In other words, Smith earned more than 66.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,696 out of 14,075 | 67th |
Division Manufacturing | 1,672 out of 5,486 | 70th |
Major group Chemicals And Allied Products | 519 out of 1,900 | 73rd |
Industry group Drugs | 383 out of 1,543 | 75th |
Industry Pharmaceutical Preparations | 303 out of 1,173 | 74th |
Source: SEC filing on June 20, 2017.
Smith's colleagues
We found five more compensation records of executives who worked with Karen Smith at Jazz Pharmaceuticals in 2016.
2016
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2016
Russell Cox
Jazz Pharmaceuticals
Chief Operating Officer
2016
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2016
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2016
Michael Miller
Jazz Pharmaceuticals